InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,470.03
(
-0.23%
)
US TECH 100
19,239.60
(
-0.13%
)
Dow Jones
39,007.79
(
-0.40%
)
Brent Oil
84.72
(
-0.82%
)
Bitcoin
60,685.31
(
-1.50%
)
Post# of 462829
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rayovacAAA

Send PM Follow Ignore
Followers 16
Posts 5825
Boards Moderated 0
Alias Born 07/16/2018

rayovacAAA

Re: BAR123 post# 159527

Wednesday, 07/25/2018 11:31:17 AM

Wednesday, July 25, 2018 11:31:17 AM

Post# of 462829
Data leading to an approval is what is needed. Sorry, but it's not a mistake that AVXL is running a 2b/3 trial with more than 32 patients. If 32 was enough, why incur more expense/complexity with a larger trial population?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!